These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27213160)

  • 1. Scaffolded Antigens in Yeast Cell Particle Vaccines Provide Protection against Systemic Polyoma Virus Infection.
    Tipper DJ; Szomolanyi-Tsuda E
    J Immunol Res; 2016; 2016():2743292. PubMed ID: 27213160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.
    Vlastos A; Andreasson K; Tegerstedt K; Holländerová D; Heidari S; Forstová J; Ramqvist T; Dalianis T
    J Med Virol; 2003 Jun; 70(2):293-300. PubMed ID: 12696121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice.
    Gedvilaite A; Zvirbliene A; Staniulis J; Sasnauskas K; Krüger DH; Ulrich R
    Viral Immunol; 2004; 17(1):51-68. PubMed ID: 15018662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
    Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
    Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunization with whole yeast producing viral capsid antigen provokes a stronger humoral immune response than purified viral capsid antigen.
    Kim HJ; Lee JY; Kang HA; Lee Y; Park EJ; Kim HJ
    Lett Appl Microbiol; 2014 Mar; 58(3):285-91. PubMed ID: 24251903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles.
    Szomolanyi-Tsuda E; Le QP; Garcea RL; Welsh RM
    J Virol; 1998 Aug; 72(8):6665-70. PubMed ID: 9658113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of T-cell deficient mice against polyomavirus infection using viral pseudocapsids or temperature sensitive mutants.
    Heidari S; Vlastos A; Ramqvist T; Clark B; Griffin BE; Garcia MI; Perez M; Amati P; Dalianis T
    Vaccine; 2002 Feb; 20(11-12):1571-8. PubMed ID: 11858864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids.
    Rollman E; Ramqvist T; Zuber B; Tegerstedt K; Kjerrström Zuber A; Klingström J; Eriksson L; Ljungberg K; Hinkula J; Wahren B; Dalianis T
    Vaccine; 2003 Jun; 21(19-20):2263-7. PubMed ID: 12744856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.
    Franzén AV; Tegerstedt K; Holländerova D; Forstová J; Ramqvist T; Dalianis T
    In Vivo; 2005; 19(2):323-6. PubMed ID: 15796193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.
    Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
    BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and biomedical applications of virus-like particles derived from polyomaviruses.
    Teunissen EA; de Raad M; Mastrobattista E
    J Control Release; 2013 Nov; 172(1):305-321. PubMed ID: 23999392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.
    Tegerstedt K; Franzén AV; Andreasson K; Joneberg J; Heidari S; Ramqvist T; Dalianis T
    Anticancer Res; 2005; 25(4):2601-8. PubMed ID: 16080500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
    Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
    Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.
    Sasnauskas K; Bulavaite A; Hale A; Jin L; Knowles WA; Gedvilaite A; Dargeviciūte A; Bartkeviciūte D; Zvirbliene A; Staniulis J; Brown DW; Ulrich R
    Intervirology; 2002; 45(4-6):308-17. PubMed ID: 12602348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
    Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1.
    Premanand B; Kiener TK; Meng T; Tan YR; Jia Q; Chow VT; Kwang J
    Antiviral Res; 2012 Sep; 95(3):311-5. PubMed ID: 22691220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.